Sir Rory Edward Collins FMedSci FRS

Rory Collins created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into safe, widely-used generics that annually prevent millions of heart attacks and ischaemic strokes. His large placebo-controlled trials and worldwide Cholesterol Treatment Trialists’ meta-analyses confirmed heart attack reduction, discovered stroke reduction, and demonstrated safety and efficacy in many different types of patient.

Professional position

  • Nuffield Professor of Population Health, Nuffield Department of Population Health, University of Oxford

Subject groups

  • Health and human sciences

    Clinical epidemiology, Medical statistics and demography, Medicine, clinical studies

Sir Rory Edward Collins FMedSci FRS
Elected 2015